NIM
VRTX icon

NEOS Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

NEOS Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96M Buy
193,306
+19,219
+11% +$8.52M 0.35% 47
2026
Q1 		$77.7M Buy
174,087
+27,889
+19% +$13M 0.39% 48
2025
Q4 		$66.3M Buy
146,198
+32,665
+29% +$14.1M 0.38% 47
2025
Q3 		$44.5M Buy
113,533
+37,296
+49% +$15.6M 0.33% 58
2025
Q2 		$33.9M Buy
76,237
+24,915
+49% +$11.5M 0.42% 44
2025
Q1 		$24.9M Buy
51,322
+7,991
+18% +$3.72M 0.47% 44
2024
Q4 		$17.4M Buy
43,331
+7,732
+22% +$3.58M 0.41% 44
2024
Q3 		$16.6M Buy
35,599
+5,622
+19% +$2.7M 0.5% 42
2024
Q2 		$14.1M Buy
29,977
+6,087
+25% +$2.64M 0.58% 29
2024
Q1 		$9.99M Buy
23,890
+9,490
+66% +$4.01M 0.62% 29
2023
Q4 		$5.86M Buy
14,400
+3,283
+30% +$1.21M 0.55% 33
2023
Q3 		$3.87M Buy
+11,117
New +$3.89M 0.49% 45

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

NEOS Investment Management's VRTX Position: Q2 2026 in Review

NEOS Investment Management increased its Vertex Pharmaceuticals (VRTX) stake by 11% in Q2 2026, buying an estimated $8.52M and bringing the position to 193,306 shares worth $96M. The position accounts for 0.35% of the portfolio, ranked #47.

NEOS Investment Management first reported a position in VRTX in Q3 2023 and has held it in 12 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • NEOS Investment Management held 193,306 shares of Vertex Pharmaceuticals worth $96M as of Q2 2026.
  • NEOS Investment Management bought 19,219 Vertex Pharmaceuticals shares in Q2 2026, an estimated $8.52M.
  • Vertex Pharmaceuticals made up 0.35% of NEOS Investment Management's portfolio in Q2 2026, its #47 holding.
  • NEOS Investment Management first reported a position in Vertex Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.